Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:SM 18:2;O2/16:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003290 AN005388 High expression of oleoyl-ACP-hydrolase underpins life-threatening respiratory viral diseases Lung Mouse Viral infection Peter Doherty Institute for Infection and Immunity LC-MS
  logo